Cardiometabolic Considerations in Familial Chylomicronemia Syndrome
On the Frontlines of Familial Chylomicronemia SyndromeCardiometabolic Considerations in Familial Chylomicronemia Syndrome
Rethinking Risk in Heart Failure with Preserved Ejection Fraction
Heart MattersRethinking Risk in Heart Failure with Preserved Ejection Fraction
Connecting Chronic Kidney Disease and Cardiovascular Risk in Primary Care
Heart MattersConnecting Chronic Kidney Disease and Cardiovascular Risk in Primary Care
The Cardiovascular Dimension of Psoriatic Arthritis
Living RheumThe Cardiovascular Dimension of Psoriatic Arthritis
Steroidal vs Nonsteroidal MRAs: Implications for Heart Failure Care
Heart MattersSteroidal vs Nonsteroidal MRAs: Implications for Heart Failure Care
- advertisement
- 5 questions
- advertisement
Quick Takes in ATTR-CM: Symptoms and Comorbidities
Medical Industry FeatureQuick Takes in ATTR-CM: Symptoms and Comorbidities
Rethinking Cardiovascular Risk: Uncovering the Blind Spots
Conversations in CV Risk AssessmentRethinking Cardiovascular Risk: Uncovering the Blind Spots
Elevating CV Risk Assessment: Why uACR Deserves a Seat at the Table
Conversations in CV Risk AssessmentElevating CV Risk Assessment: Why uACR Deserves a Seat at the Table
Primary Care and Cardiology: Shared Responsibility in Albuminuria Detection
Conversations in CV Risk AssessmentPrimary Care and Cardiology: Shared Responsibility in Albuminuria Detection
Groundbreaking AI Models Transform Cardiovascular Diagnosis
Medical Industry FeatureGroundbreaking AI Models Transform Cardiovascular Diagnosis
Shared Decision-Making in Pulmonary Arterial Hypertension: Strategies for PAH Treatment Initiation and Support
Medical Industry FeatureShared Decision-Making in Pulmonary Arterial Hypertension: Strategies for PAH Treatment Initiation and Support
- 05/14/2026
- 05/13/2026
- 05/13/2026
- 05/12/2026
- 05/11/2026
- 05/11/2026























































